148 related articles for article (PubMed ID: 11244333)
1. Micrometastatic p53-positive cells in the lymph nodes of early stage epithelial ovarian cancer: prognostic significance.
Suzuki M; Ohwada M; Saga Y; Kohno T; Takei Y; Sato I
Oncology; 2001; 60(2):170-5. PubMed ID: 11244333
[TBL] [Abstract][Full Text] [Related]
2. Micrometastatic P53-positive cells in the lymph nodes of non-small-cell lung cancer: prognostic significance.
Dobashi K; Sugio K; Osaki T; Oka T; Yasumoto K
J Thorac Cardiovasc Surg; 1997 Sep; 114(3):339-46. PubMed ID: 9305185
[TBL] [Abstract][Full Text] [Related]
3. Detection of micrometastatic tumor cells in pN0 lymph nodes of patients with completely resected nonsmall cell lung cancer: impact on recurrence and Survival.
Gu CD; Osaki T; Oyama T; Inoue M; Kodate M; Dobashi K; Oka T; Yasumoto K
Ann Surg; 2002 Jan; 235(1):133-9. PubMed ID: 11753052
[TBL] [Abstract][Full Text] [Related]
4. Prognostic value of genetically diagnosed lymph node micrometastasis in non-small cell lung carcinoma cases.
Hashimoto T; Kobayashi Y; Ishikawa Y; Tsuchiya S; Okumura S; Nakagawa K; Tokuchi Y; Hayashi M; Nishida K; Hayashi S; Hayashi J; Tsuchiya E
Cancer Res; 2000 Nov; 60(22):6472-8. PubMed ID: 11103815
[TBL] [Abstract][Full Text] [Related]
5. Mutant p53 protein overexpression is associated with poor outcome in patients with well or moderately differentiated ovarian carcinoma.
Levesque MA; Katsaros D; Yu H; Zola P; Sismondi P; Giardina G; Diamandis EP
Cancer; 1995 Mar; 75(6):1327-38. PubMed ID: 7882283
[TBL] [Abstract][Full Text] [Related]
6. Micrometastasis in regional lymph nodes of extirpated colorectal carcinoma: immunohistochemical study using anti-cytokeratin antibodies AE1/AE3.
Palma RT; Waisberg J; Bromberg SH; Simão AB; Godoy AC
Colorectal Dis; 2003 Mar; 5(2):164-8. PubMed ID: 12780907
[TBL] [Abstract][Full Text] [Related]
7. Morphological and immunohistochemical characterization of isolated tumor cells by p53 status in gastrointestinal tumors.
Milsmann C; Füzesi L; Heinmöller E; Krause P; Werner C; Becker H; Horstmann O
Langenbecks Arch Surg; 2008 Jan; 393(1):49-58. PubMed ID: 17876601
[TBL] [Abstract][Full Text] [Related]
8. Should lymph node micrometastasis be considered in node staging for gastric cancer?: the significance of lymph node micrometastasis in gastric cancer.
Lee CM; Cho JM; Jang YJ; Park SS; Park SH; Kim SJ; Mok YJ; Kim CS; Kim JH
Ann Surg Oncol; 2015 Mar; 22(3):765-71. PubMed ID: 25201506
[TBL] [Abstract][Full Text] [Related]
9. EGFR, c-erbB2 and p53 protein in the primary lesions and paired metastatic regional lymph nodes in breast cancer.
Tsutsui S; Ohno S; Murakami S; Kataoka A; Kinoshita J; Hachitanda Y
Eur J Surg Oncol; 2002 Jun; 28(4):383-7. PubMed ID: 12099646
[TBL] [Abstract][Full Text] [Related]
10. Immunohistochemistry analysis of micrometastasis in pretreatment lymph nodes from patients with esophageal cancer.
Jiao X; Eslami A; Ioffe O; Kwong KF; Henry M; Zeng Q; Refaely Y; Burrows W; Gamliel Z; Krasna MJ
Ann Thorac Surg; 2003 Oct; 76(4):996-9; discussion 999-1000. PubMed ID: 14529974
[TBL] [Abstract][Full Text] [Related]
11. [P53-status in primary ovarian carcinomas, ovarian metastases of neoplasms in other sites and benign ovarian tumors: predictive value in comparison to histopathological parameters].
Casper F; Weikel W; Schaffrath M; Kuner RP; Hoffmann G; Pollow B; Pollow K
Zentralbl Gynakol; 2000; 122(3):153-9. PubMed ID: 10756599
[TBL] [Abstract][Full Text] [Related]
12. Prognostic evaluation and review of immunohistochemically detected disseminated tumor cells in peritumoral lymph nodes of patients with pN0 colorectal cancer.
Rosenberg R; Friederichs J; Gertler R; Hoos A; Mueller J; Nahrig J; Nekarda H; Siewert JR
Int J Colorectal Dis; 2004 Sep; 19(5):430-7. PubMed ID: 14716495
[TBL] [Abstract][Full Text] [Related]
13. Prognostic significance of p53 immunostaining in epithelial ovarian cancer.
Hartmann LC; Podratz KC; Keeney GL; Kamel NA; Edmonson JH; Grill JP; Su JQ; Katzmann JA; Roche PC
J Clin Oncol; 1994 Jan; 12(1):64-9. PubMed ID: 8270986
[TBL] [Abstract][Full Text] [Related]
14. [Multi-antibody combined determination of lymph node micrometastasis in patients with gastric cancer].
Wang GY; Wang SJ; Li Y; Wang LL; Wang XL; Song ZC; Fan LQ
Ai Zheng; 2004 May; 23(5):559-63. PubMed ID: 15142454
[TBL] [Abstract][Full Text] [Related]
15. p53 as a new prognostic factor for lymph node metastasis in penile carcinoma: analysis of 82 patients treated with amputation and bilateral lymphadenectomy.
Lopes A; Bezerra AL; Pinto CA; Serrano SV; de MellO CA; Villa LL
J Urol; 2002 Jul; 168(1):81-6. PubMed ID: 12050497
[TBL] [Abstract][Full Text] [Related]
16. c-erbB-2, p53, and nm23 proteins as prognostic factors in patients with epithelial ovarian carcinoma.
Tomić S; Ilić Forko J; Babić D; Sundov D; Kuret S; Andelinović S
Croat Med J; 2003 Aug; 44(4):429-34. PubMed ID: 12950146
[TBL] [Abstract][Full Text] [Related]
17. Clinical significance of lymph node micrometastasis in ampullary carcinoma.
Sakata E; Shirai Y; Yokoyama N; Wakai T; Sakata J; Hatakeyama K
World J Surg; 2006 Jun; 30(6):985-91. PubMed ID: 16736326
[TBL] [Abstract][Full Text] [Related]
18. Quantification of p53 in epithelial ovarian cancer.
Geisler JP; Geisler HE; Wiemann MC; Givens SS; Zhou Z; Miller GA
Gynecol Oncol; 1997 Sep; 66(3):435-8. PubMed ID: 9299258
[TBL] [Abstract][Full Text] [Related]
19. Expression analysis and RNA localization of PAI-RBP1 (SERBP1) in epithelial ovarian cancer: association with tumor progression.
Koensgen D; Mustea A; Klaman I; Sun P; Zafrakas M; Lichtenegger W; Denkert C; Dahl E; Sehouli J
Gynecol Oncol; 2007 Nov; 107(2):266-73. PubMed ID: 17698176
[TBL] [Abstract][Full Text] [Related]
20. Immunohistochemical detection of mutant p53 protein in regional lymph nodes is associated with adverse outcome in stage II colorectal cancer.
Clarke G; Ryan E; Crowe J; O'Keane JC; MacMathúna P
Eur J Histochem; 1999; 43(4):311-6. PubMed ID: 10682269
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]